Brief: Galectin Therapeutics Inc Files For Mixed Shelf Offering Of Up To $100 Million - SEC Filing
April 14 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS INC FILES FOR MIXED SHELF OFFERING
OF UP
TO $100 MILLION - SEC FILING
Source text for Eikon: ID:
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study